• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

The 16th US-Japan Cellular and Gene Therapy Conference Agenda

Potential Applications of Mesenchymal Multipotent Stromal Cells

Natcher Conference Center
Building 45, Room E1/E2, National Institutes of Health
Bethesda, Maryland 20892

Thursday, February 28, 2013


The conference is jointly supported by the Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration (FDA) and the Ministry of Education, Culture, Sports, Science and Technology, Japan under the US-Japan Cooperative Research Program. The goal of the conference is to exchange ideas on cutting edge areas of biomedical research and enhance opportunities for collaborations among scientists from the US and Japan. The scientific theme of our joint annual meetings has been diverse. The invited speakers from Japan and the US will discuss advances in this exciting field of regenerative medicine research.

Seating is limited to 150 attendees and is on a first-come-first-served basis. No prior registration is required. No videocast is arranged for the meeting. For more information, please contact S. Rafat Husain by e-mailing syed.husain@fda.hhs.gov or phone at (301) 827-0475.


Program


 

8:00 a.m. – 8:30 a.m.Registration
Coffee and Breakfast
ModeratorS. Rafat Husain, Senior Staff Scientist, Division of Cellular and Gene Therapies, CBER, US Food and Drug Administration, Bethesda, Maryland
8:30 a.m. – 8:35 a.m.Opening Remarks
Celia Witten
, Director, Office of Cellular, Tissue and Gene Therapies, CBER, US Food and Drug Administration, Rockville, Maryland
8:35 a.m. – 8:40 a.m.Yoshikazu Ohya, Professor, Department of Integrated Biosciences Graduate School of Frontier Sciences, University of Tokyo, Japan

 


AM Session


 

ModeratorsJunya Toguchida, Professor, Department of Tissue Regeneration, Institute for Frontier Medical Sciences; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto
Raj K Puri, Director,Division of Cellular and Gene Therapies, CBER, FDA, Bethesda, Maryland
8:40 a.m. – 9:10 a.m.Applications of mesenchymal stem cells for regenerative medicine: current status in Japan
Professor, Department of Tissue Regeneration, Institute for Frontier Medical Sciences; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto
Junya Toguchida,
9:10 a.m. – 9:40 a.m.Towards improved characterization of MSCs
Steven Bauer,
Chief, Cellular and Tissue Therapy Branch, Division of
Cellular and Gene Therapies, CBER, Bethesda, Maryland
9:40 a.m. – 10:10 a.m.Cell/tissue manufacturing activities in Osaka University Hospital
Sachiko Ezoe, Medical Center for Translational Research, Osaka University Hospital, Suita City, Osaka

 


 

10:10 a.m. – 10:40 a.m.Coffee Break

 


 

10:40 a.m. – 11:10 a.m.Production and clinical use of bone marrow stromal cells at the NIH Clinical CenterDavid Stroncek, Chief, Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland
11:10 a.m. – 11:40 a.m.Development of new cell therapy using bone marrow derived cell for liver cirrhosis patientShuji Terai, Associate Professor, Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi

 


 

11:40 p.m. – 1:00 p.m.Lunch

 


PM Session


 

ModeratorsJennifer Elisseeff, Professor, Ophthalmology and Biomedical Engineering, Tissue Engineering Laboratory, Johns Hopkins University, Baltimore, Maryland
Norimasa Nakamura, Professor, Institute for Medical Science in Sports, Osaka Health Science University, and the center for Advanced Medical Engineering and Informatics, Osaka University, Department of Orthopedics, Osaka University Graduate School of Medicine, Osaka
1:00 p.m. – 1:30 p.m.Biomaterials to direct stem cell function
Jennifer Elisseeff,
Professor, Ophthalmology and Biomedical Engineering, Tissue Engineering Laboratory, Johns Hopkins University, Baltimore, Maryland
1:30 p.m. – 2:00 p.m.Cartilage Repair using a scaffold-free tissue engineered construct derived from synovial mesenchymal stem cells
Norimasa Nakamura, Professor, Institute for Medical Science in Sports, Osaka Health Science University, and the center for Advanced Medical Engineering and Informatics, Osaka University, Department of Orthopedics, Osaka University Graduate School of Medicine, Osaka
2:00 p.m. – 2:30 p.m.Bridging Stem Cell Technology with Tissue Vascularization in Regenerative Medicine
John P. Fisher, Professor, Fischell Department of Bioengineering, University of Maryland

 


 

2:30 p.m. – 3:00 p.m.Coffee Break

 


 

3:00 p.m. – 3:30 p.m.Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for alveolar bone tissue engineering: basic science to clinical translation
Hideaki Kagami, Project Associate Professor, Tissue Engineering Research Group, Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, and Department of Oral and Maxillofacial Surgery, Matsumoto Dental University
3:30 p.m. – 4:00 p.m.Mesenchymal stromal cells to treat complications following allogeneic stem cell transplantation
John Barrett, Chief, Stem Cell Allogeneic Transplant Section, Hematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland
4:00 p.m. - 4:30 p.m.Local transplantation of G-CSF-mobilized CD34+ cells in Patients with non-union
Ryosuke Kuroda, Associate Professor, Department of Orthopedic Surgery, Kobe University Graduate School of Medicine, Kobe

 


Thank you for your participation!


 

Organizers: Syed R Husain, Ph.D.
Raj K Puri, M.D., Ph.D.

Tumor Vaccines and Biotechnology Branch
Division of Cellular and Gene Therapies
NIH Bldg. 29B, Room 2G07, HFM-735
Bethesda, Maryland, 20892
Ph. 301-827-0475; Fax 301-827-0449
syed.husain@fda.hhs.gov
raj.puri@fda.hhs.gov
Yoshikazu Ohya, Ph.D.
Professor, Division of Biosciences
Department of Integrated Biosciences
Graduate School of Frontier Sciences
University of Tokyo
Bldg. FSB-101, 5-1-5 Kashiwanoha
Kashiwa, Chiba Prefecture 277-8562
Japan
ohya@k.u-tokyo.ac.jp